Chronic hepatitis C in HIV-infected patients:: Low eligibility and applicability of therapy with pegylated interferon-α plus ribavirin

被引：32

作者：

Rauch, A ^{[1
]}

Egger, M

Reichen, J

Furrer, H

机构：

[1] Univ Hosp Bern, Div Infect Dis, Inselspital, CH-3010 Bern, Switzerland

[2] Univ Hosp Bern, Inst Clin Pharmacol, Inselspital, CH-3010 Bern, Switzerland

来源：

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2005年 / 38卷 / 02期

关键词：

D O I：

10.1097/01.qai.0000148535.97081.72

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：238 / 240

页数：3

共 13 条

[1] Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection [J].

Bica, I ;

McGovern, B ;

Dhar, R ;

Stone, D ;

McGowan, K ;

Scheib, R ;

Snydman, DR .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) :492-497

[2] Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons [J].

Chung, RT ;

Andersen, J ;

Volberding, P ;

Robbins, GK ;

Liu, T ;

Sherman, KE ;

Peters, MG ;

Koziel, MJ ;

Bhan, AK ;

Alston, B ;

Colquhoun, D ;

Nevin, T ;

Harb, G ;

van der Horst, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) :451-459

[3] Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: Low eligibility for interferon treatment [J].

Fleming, CA ;

Craven, DE ;

Thornton, D ;

Tumilty, S ;

Nunes, D .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (01) :97-100

[4] Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection [J].

Fultz, SL ;

Justice, AC ;

Butt, AA ;

Rabeneck, L ;

Weissman, S ;

Rodriguez-Barradas, M .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (08) :1039-1046

[5] Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study [J].

Greub, G ;

Ledergerber, B ;

Battegay, M ;

Grob, P ;

Perrin, L ;

Furrer, H ;

Burgisser, P ;

Erb, P ;

Boggian, K ;

Piffaretti, JC ;

Hirschel, B ;

Janin, P ;

Francioli, P ;

Flepp, M ;

Telenti, A .

LANCET, 2000, 356 (9244) :1800-1805

[6] Hepatitis C virus infection in San Francisco's HIV-infected urban poor - High prevalence but low treatment rates [J].

Hall, CS ;

Charlebois, ED ;

Hahn, JA ;

Moss, AR ;

Bangsberg, DR .

JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (04) :357-365

[7] Hepatitis C virus infection - Related morbidity and mortality among patients with human immunodeficiency virus infection [J].

Monga, HK ;

Rodriguez-Barradas, MC ;

Breaux, K ;

Khattak, K ;

Troisi, CL ;

Velez, M ;

Yoffe, B .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) :240-247

[8] Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients [J].

Moreno, L ;

Quereda, C ;

Moreno, A ;

Perez-Elías, MJ ;

Antela, A ;

Casado, JL ;

Dronda, F ;

Mateos, ML ;

Bárcena, R ;

Moreno, S .

AIDS, 2004, 18 (01) :67-73

[9] Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients [J].

Pérez-Olmeda, M ;

Núñez, M ;

Romero, M ;

González, J ;

Castro, A ;

Arribas, JR ;

Pedreira, J ;

Barreiro, P ;

García-Samaniego, J ;

Martín-Carbonero, L ;

Jiménez-Nácher, I ;

Soriano, V .

AIDS, 2003, 17 (07) :1023-1028

[10]

PERRONE C, 2004, 15 INT AIDS C BANGK

← 1 2 →